SEATTLE--(BUSINESS WIRE)--Tasso, Inc., the leading provider of patient-centric, clinical-grade blood collection solutions, today announced that the TassoOne™ Plus, a new high-volume liquid blood ...
With the increasing number, complexity, and diversity of biomarkers to be tested in support of precision medicine approaches, limited tissue availability and patient health status can be barriers to ...
Researchers used a panel to assess the presence of circulating tumor DNA in plasma samples and detected changes in genes related to the development of adenocarcinoma that indicated both actionability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback